{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1259159434", "close" : "1259182834", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
ap

Novavax 3Q loss narrows on cost cuts

Novavax's 3rd-quarter loss narrows following cost-cutting program

  • On 11:13 am EST, Friday November 6, 2009

ROCKVILLE, Md. (AP) -- Drug developer Novavax Inc. said its third-quarter loss narrowed slightly on lower expenses following staff cuts and other cost cutting.

Novavax lost $7.5 million, or 8 cents per share, compared with a loss of $7.8 million, or 12 cents per share, during the same period a year prior. Revenue rose 3.6 percent to $201,000 from $194,000.

Analysts polled by Thomson Reuters expected a loss of 9 cents per share.

Operating costs and expenses fell 15 percent to $8.5 million.

The company is currently developing a pandemic and seasonal flu vaccine.

Shares of Novavax fell 13 cents, or 3.2 percent, to $3.90 in midday trading. The stock has traded between 52 cents and $7.79 over the last 52 weeks.

Sponsored Links

Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.